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Introduction: Selegiline, a selective monoamine oxidase type B inhibitor, has been 
shown to have neurotrophic and anti-apoptotic properties and to protect neurons in 
experimental models of cerebral ischemia. The aim of this study was to investigate 
whether selegiline could enhance cognitive and functional recovery in stroke disease. 
Selegiline is a drug that has demonstrated antioxidant and neuroprotective effects, as 
documented in the permanent middle cerebral artery occlusion model in rats. Widely 
used in the treatment of Parkinson's disease and in recent studies showed anti-
inflammatory and anti-apoptotic properties. It has been shown to reduce total brain 
damage after transient hypoxia– Ischemia. 
Methods and Results: The male rats were randomized into four groups: Control 
groups, Control + Selegiline (2 mg/kg), stroke induction groups and stroke+ Selegiline 
(2 mg/kg). Selegiline was gavaged after 4 days from beginning of the investigation. In 
this regard, we tested whether 1) Administration of selegiline is able to inhibit 
abnormality behaviors related to global ischemia in Male Rats 2) Behavioral changes 
are associated with mitochondrial dysfunction in the hippocampus and 3) 
Administration of selegiline is able to alter immune-inflammatory factors in the 
hippocampus. Therefore, using valid and qualified behavioral tests for the assessment 
of stroke like behaviors such as novel object recognition test (NOR) were used for 
confirmation of stroke induction in rats. Then, animals were sacrificed and hippocampi 
were dissected out and stored at -80 °C. The samples were divided into two different 
groups; first set of samples were used for preparation of tissue homogenate, on which 
measurement of oxidative stress parameters and nitrite levels were performed. The 
second set of samples were fixed in 10% formalin, sectioned, and stained with 
hematoxylin and eosin (H&E) for pathological evaluations. The statistical analysis 
showed a significant improvement in most neuropsychological tests after two weeks in 
the study group. 
Conclusions: Data on experimental models of cerebral ischemia have suggested a 
marked activation of the nigrostriatal dopaminergic system by selegiline that might 
contribute to the protection against ischemia-induced neurodegeneration. 
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